Atlas Trials

A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL)

Clinical trial NCT04956666 · COMPLETED

Trial details

NCT number
NCT04956666
Sponsor
Institut de Recherches Internationales Servier
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2021-06-15
Primary completion
2023-01-23
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.